These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22722622)

  • 1. Parkinson syndrome. Heterogeneity of etiology; heterogeneity of pathogenesis?
    Albin RL; Dauer WT
    Neurology; 2012 Jul; 79(3):202-3. PubMed ID: 22722622
    [No Abstract]   [Full Text] [Related]  

  • 2. GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure.
    Brockmann K; Hilker R; Pilatus U; Baudrexel S; Srulijes K; Magerkurth J; Hauser AK; Schulte C; Csoti I; Merten CD; Gasser T; Berg D; Hattingen E
    Neurology; 2012 Jul; 79(3):213-20. PubMed ID: 22722629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOS knockouts and neuroprotection.
    Grünewald T; Beal MF
    Nat Med; 1999 Dec; 5(12):1354-5. PubMed ID: 10581072
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting glucocerebrosidase: Reduced enzymatic activity and Parkinson's disease.
    Raj Kumar K
    Mov Disord; 2015 Oct; 30(12):1620. PubMed ID: 26260953
    [No Abstract]   [Full Text] [Related]  

  • 5. The need for appropriate genotyping strategies for glucocerebrosidase mutations in cohorts with Parkinson disease.
    Gutti U; Fung HC; Hruska KS; Lamarca ME; Chen CM; Wu YR; Sidransky E
    Arch Neurol; 2008 Jun; 65(6):850-1; author reply 851. PubMed ID: 18541817
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between Parkinson's disease and glucocerebrosidase mutations in Brazil.
    Spitz M; Rozenberg R; Pereira Lda V; Reis Barbosa E
    Parkinsonism Relat Disord; 2008; 14(1):58-62. PubMed ID: 17703984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration and energy metabolism: from chemistry to clinics.
    Blandini F; Braunewell KH; Manahan-Vaughan D; Orzi F; Sarti P
    Cell Death Differ; 2004 Apr; 11(4):479-84. PubMed ID: 14713955
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations in the glucocerebrosidase gene and Parkinson disease: phenotype-genotype correlation.
    Aharon-Peretz J; Badarny S; Rosenbaum H; Gershoni-Baruch R
    Neurology; 2005 Nov; 65(9):1460-1. PubMed ID: 16148263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetrance of PD in Glucocerebrosidase Gene Mutation Carriers.
    Sidransky E; Hart PS
    Neurology; 2012 Jul; 79(1):106-7. PubMed ID: 22753448
    [No Abstract]   [Full Text] [Related]  

  • 10. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Eblan MJ; Walker JM; Sidransky E
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15716572
    [No Abstract]   [Full Text] [Related]  

  • 11. Transglutaminases in neurodegenerative disorders.
    Bailey CD; Tucholski J; Johnson GV
    Prog Exp Tumor Res; 2005; 38():139-57. PubMed ID: 15746534
    [No Abstract]   [Full Text] [Related]  

  • 12. Early visual memory deficits: a neuropsychological marker of GBA mutations in PD?
    Daniele A; Albanese A
    Neurology; 2012 May; 78(18):1372-3. PubMed ID: 22442440
    [No Abstract]   [Full Text] [Related]  

  • 13. The L444P GBA mutation is associated with early-onset Parkinson's disease in Mexican Mestizos.
    González-Del Rincón Mde L; Monroy Jaramillo N; Suárez Martínez AI; Yescas Gómez P; Boll Woehrlen MC; López López M; Alonso Vilatela ME
    Clin Genet; 2013 Oct; 84(4):386-7. PubMed ID: 23448517
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa.
    Lesage S; Condroyer C; Hecham N; Anheim M; Belarbi S; Lohman E; Viallet F; Pollak P; Abada M; Dürr A; Tazir M; Brice A;
    Neurology; 2011 Jan; 76(3):301-3. PubMed ID: 21242499
    [No Abstract]   [Full Text] [Related]  

  • 15. The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
    Zimran A; Neudorfer O; Elstein D
    N Engl J Med; 2005 Feb; 352(7):728-31; author reply 728-31. PubMed ID: 15719452
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenic mechanisms of neurodegeneration in Parkinson disease.
    Mullin S; Schapira AH
    Neurol Clin; 2015 Feb; 33(1):1-17. PubMed ID: 25432720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians.
    Socal MP; Bock H; Michelin-Tirelli K; Hilbig A; Saraiva-Pereira ML; Rieder CR; Jardim LB
    Parkinsonism Relat Disord; 2009 Jan; 15(1):76-8. PubMed ID: 18358758
    [No Abstract]   [Full Text] [Related]  

  • 18. Putting a PARKINg brake on neurodegeneration.
    Lu B
    Mol Psychiatry; 2004 Jan; 9(1):6-7. PubMed ID: 14699438
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia.
    Emelyanov A; Boukina T; Yakimovskii A; Usenko T; Drosdova A; Zakharchuk A; Andoskin P; Dubina M; Schwarzman A; Pchelina S
    Mov Disord; 2012 Jan; 27(1):158-9. PubMed ID: 21915911
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations.
    Gan-Or Z; Giladi N; Orr-Urtreger A
    Brain; 2009 Oct; 132(Pt 10):e125. PubMed ID: 19502295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.